Taimour Langaee

8.5k total citations · 1 hit paper
152 papers, 5.5k citations indexed

About

Taimour Langaee is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Taimour Langaee has authored 152 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 44 papers in Pharmacology and 35 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Taimour Langaee's work include Pharmacogenetics and Drug Metabolism (43 papers), Hormonal Regulation and Hypertension (21 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Taimour Langaee is often cited by papers focused on Pharmacogenetics and Drug Metabolism (43 papers), Hormonal Regulation and Hypertension (21 papers) and Eicosanoids and Hypertension Pharmacology (12 papers). Taimour Langaee collaborates with scholars based in United States, Egypt and Saudi Arabia. Taimour Langaee's co-authors include Julie A. Johnson, Yan Gong, Peter W. Stacpoole, Rhonda M. Cooper‐DeHoff, Mostafa Ronaghi, Brian F. Gage, Charles Eby, Larisa H. Cavallari, Amber L. Beitelshees and Carl J. Pepine and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Taimour Langaee

149 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

2008 595 citations Taimour Langaee et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taimour Langaee United States	37	2.5k	1.5k	1.2k	1.0k	712	152	5.5k
Manuel Romero‐Gómez Spain	55	1.4k 0.6×	1.5k 1.0×	3.0k 2.6×	589 0.6×	773 1.1×	375	14.7k
Han Moshage Netherlands	53	827 0.3×	2.8k 1.9×	722 0.6×	520 0.5×	1.6k 2.3×	196	9.9k
Rajiv Jalan United Kingdom	76	3.0k 1.2×	1.9k 1.3×	654 0.6×	329 0.3×	675 0.9×	381	18.6k
Jordi Camps Spain	46	772 0.3×	1.4k 1.0×	794 0.7×	518 0.5×	305 0.4×	252	7.1k
In‐Jin Jang South Korea	40	1.2k 0.5×	1.5k 1.0×	571 0.5×	293 0.3×	1.6k 2.2×	306	5.9k
Kyoung‐Ah Kim South Korea	35	1.0k 0.4×	1.1k 0.7×	448 0.4×	462 0.5×	840 1.2×	122	3.7k
Diana M. Shih United States	49	648 0.3×	3.2k 2.2×	912 0.8×	680 0.7×	281 0.4×	80	9.6k
Eleni Aklillu Sweden	42	2.5k 1.0×	922 0.6×	396 0.3×	209 0.2×	1.2k 1.7×	174	6.3k
Ron H. N. van Schaik Netherlands	53	2.8k 1.1×	2.1k 1.4×	661 0.6×	427 0.4×	2.7k 3.8×	242	9.3k
Zeruesenay Desta United States	45	4.0k 1.6×	1.5k 1.0×	623 0.5×	664 0.7×	2.4k 3.3×	171	8.6k

Countries citing papers authored by Taimour Langaee

Since Specialization

Citations

This map shows the geographic impact of Taimour Langaee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taimour Langaee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taimour Langaee more than expected).

Fields of papers citing papers by Taimour Langaee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taimour Langaee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taimour Langaee. The network helps show where Taimour Langaee may publish in the future.

Co-authorship network of co-authors of Taimour Langaee

This figure shows the co-authorship network connecting the top 25 collaborators of Taimour Langaee. A scholar is included among the top collaborators of Taimour Langaee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taimour Langaee. Taimour Langaee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langaee, Taimour, et al.. (2024). Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact. Clinical Pharmacology & Therapeutics. 116(4). 1082–1089. 2 indexed citations

Langaee, Taimour, Daqing Wang, Rolf Renne, et al.. (2024). Circulating microRNA Biomarkers of Thiazide Response in Hypertension. Journal of the American Heart Association. 13(4). e032433–e032433. 4 indexed citations

Ortega‐Paz, Luis, Francesco Franchi, Fabiana Rollini, et al.. (2024). Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD. JACC Basic to Translational Science. 9(7). 865–876. 2 indexed citations

Bae, Ji‐Hyun, Yan Gong, Taimour Langaee, et al.. (2024). Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection. Antimicrobial Agents and Chemotherapy. 68(9). e0054924–e0054924. 1 indexed citations

Sheikh, Sophia, Rosemarie Fernandez, Carmen Smotherman, et al.. (2023). A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults. Clinical and Translational Science. 16(11). 2331–2344. 3 indexed citations

Waheed, Nida, Michael G. Fradley, David L. DeRemer, et al.. (2021). Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center. Cardio-Oncology. 7(1). 10–10. 29 indexed citations

Archampong, Timothy, Yiqing Chen, Margaret Lartey, et al.. (2019). Brief Report: Relationship Between ABCC4 SNPs and Hepatitis B Virus Suppression During Tenofovir-Containing Antiretroviral Therapy in Patients With HIV/HBV Coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(4). 421–425. 3 indexed citations

Smith, D. Max, Kristin Weitzel, Amanda R. Elsey, et al.. (2019). CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics in Medicine. 21(8). 1842–1850. 105 indexed citations

Langaee, Taimour, et al.. (2019). Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping Panel. Genetic Testing and Molecular Biomarkers. 23(3). 209–214. 3 indexed citations

10.

Langaee, Taimour, Richard E. Wagner, Lloyd P. Horne, et al.. (2018). Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay. Genetic Testing and Molecular Biomarkers. 22(4). 266–269. 9 indexed citations

11.

Langaee, Taimour, et al.. (2017). Cross-Validation of High-Resolution Melting Analysis-Based Genotyping Platform. Genetic Testing and Molecular Biomarkers. 21(4). 259–264. 3 indexed citations

12.

Bannister, Thomas D., Hao Tan, Shouguang Jin, et al.. (2017). A Rapid Phenotypic Whole-Cell Screening Approach for the Identification of Small-Molecule Inhibitors That Counter β-Lactamase Resistance in Pseudomonas aeruginosa. SLAS DISCOVERY. 23(1). 55–64. 10 indexed citations

13.

Langaee, Taimour, et al.. (2016). Identification of Suitable Endogenous Normalizers for qRT-PCR Analysis of Plasma microRNA Expression in Essential Hypertension. Molecular Biotechnology. 58(3). 179–187. 39 indexed citations

14.

Rezai, Mohammad Sadegh, et al.. (2015). Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-ProducingEscherichia coliamong Uropathogens of Pediatrics in North of Iran. BioMed Research International. 2015. 1–7. 71 indexed citations

15.

Shroads, Albert L., Bonnie S. Coats, Taimour Langaee, Jonathan J. Shuster, & Peter W. Stacpoole. (2014). Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans. Drug Metabolism and Personalized Therapy. 30(1). 49–55. 4 indexed citations

16.

Theofilogiannakos, Efstratios K., Konstantinos Dean Boudoulas, Taimour Langaee, et al.. (2014). Floppy mitral valve/mitral valve prolapse syndrome: Beta-adrenergic receptor polymorphism may contribute to the pathogenesis of symptoms. Journal of Cardiology. 65(5). 434–438. 13 indexed citations

17.

McDonough, Caitrin W., Yan Gong, Sandosh Padmanabhan, et al.. (2013). Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12 , A1BG , and the Selectin Region and Cardiovascular Outcomes. Hypertension. 62(1). 48–54. 27 indexed citations

18.

McDonough, Caitrin W., Nancy Gillis, Abdullah Alsultan, et al.. (2013). Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study. PLoS ONE. 8(10). e76984–e76984. 11 indexed citations

19.

Vandell, Alexander G., Maximilian T. Lobmeyer, Taimour Langaee, et al.. (2012). G protein receptor kinase 4 polymorphisms. Hypertension. 60(4). 957–964. 50 indexed citations

20.

Shin, Jaekyu, Maximilian T. Lobmeyer, Yan Gong, et al.. (2006). Relation of β2-Adrenoceptor Haplotype to Risk of Death and Heart Transplantation in Patients With Heart Failure. The American Journal of Cardiology. 99(2). 250–255. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact